EP0684828A4 - Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta. - Google Patents
Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta.Info
- Publication number
- EP0684828A4 EP0684828A4 EP94910691A EP94910691A EP0684828A4 EP 0684828 A4 EP0684828 A4 EP 0684828A4 EP 94910691 A EP94910691 A EP 94910691A EP 94910691 A EP94910691 A EP 94910691A EP 0684828 A4 EP0684828 A4 EP 0684828A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tgf
- neutralization
- expansion
- stem cells
- bone marrow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1955693A | 1993-02-19 | 1993-02-19 | |
US19556 | 1993-02-19 | ||
PCT/US1994/001634 WO1994018991A1 (fr) | 1993-02-19 | 1994-02-15 | Expansion de cellules souches dans les cultures sur une longue duree de m×lle osseuse par neutralisation du facteur de croissance transformant beta |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0684828A1 EP0684828A1 (fr) | 1995-12-06 |
EP0684828A4 true EP0684828A4 (fr) | 1996-08-07 |
Family
ID=21793831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94910691A Withdrawn EP0684828A4 (fr) | 1993-02-19 | 1994-02-15 | Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0684828A4 (fr) |
JP (1) | JPH08509859A (fr) |
CA (1) | CA2155515A1 (fr) |
WO (1) | WO1994018991A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571714A (en) | 1988-12-22 | 1996-11-05 | Celtrix Pharmaceuticals, Inc. | Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use |
AU669256B2 (en) * | 1992-10-29 | 1996-05-30 | Celtrix Pharmaceuticals, Inc. | Uses of TGF-beta receptor fragment as a therapeutic agent |
DE69636656T2 (de) * | 1995-06-02 | 2007-10-04 | Gilead Sciences, Inc., Foster City | Oligonukleotidliganden mit hoher affinität für pdgf |
US5728581A (en) * | 1995-06-07 | 1998-03-17 | Systemix, Inc. | Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein |
CA2391657A1 (fr) | 1999-01-25 | 2000-07-27 | Seattle Biomedical Research Institute | Composition de cellules souches traitees a l'anti-tgf-beta, et procede correspondant |
US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
BR112014020119A2 (pt) | 2012-02-13 | 2020-10-27 | Gamida-Cell Ltd | cultura de células-tronco mesenquimais |
US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0455482A2 (fr) * | 1990-05-01 | 1991-11-06 | Becton, Dickinson and Company | Subliguée de cellules progénitrices humaines |
WO1991019513A1 (fr) * | 1990-06-20 | 1991-12-26 | Bristol-Myers Squibb Company | PROCEDES DE MODULATION DE LA PRESSION SANGUINE A L'AIDE DU FACTEUR TRANSFORMANT DE CROISSANCE-β ET DE SES ANTAGONISTES |
-
1994
- 1994-02-15 WO PCT/US1994/001634 patent/WO1994018991A1/fr not_active Application Discontinuation
- 1994-02-15 CA CA002155515A patent/CA2155515A1/fr not_active Abandoned
- 1994-02-15 JP JP6519085A patent/JPH08509859A/ja not_active Ceased
- 1994-02-15 EP EP94910691A patent/EP0684828A4/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0455482A2 (fr) * | 1990-05-01 | 1991-11-06 | Becton, Dickinson and Company | Subliguée de cellules progénitrices humaines |
WO1991019513A1 (fr) * | 1990-06-20 | 1991-12-26 | Bristol-Myers Squibb Company | PROCEDES DE MODULATION DE LA PRESSION SANGUINE A L'AIDE DU FACTEUR TRANSFORMANT DE CROISSANCE-β ET DE SES ANTAGONISTES |
Non-Patent Citations (2)
Title |
---|
See also references of WO9418991A1 * |
WAEGELL W.O. ET AL: "Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-beta", EXPERIMENTAL HEMATOLOGY, vol. 22, October 1994 (1994-10-01), NEW YORK, pages 1051 - 1057, XP000572237 * |
Also Published As
Publication number | Publication date |
---|---|
JPH08509859A (ja) | 1996-10-22 |
EP0684828A1 (fr) | 1995-12-06 |
CA2155515A1 (fr) | 1994-09-01 |
WO1994018991A1 (fr) | 1994-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0812201A4 (fr) | Amplification in vitro de cellules souches | |
IL107483A0 (en) | Bone marrow transplantation | |
AU7451596A (en) | Tissue-engineered bone repair using cultured periosteal cells | |
EP0630625A3 (fr) | Implant pour remplacer des corps vertébraux. | |
EP0171176A3 (en) | Bone repair using collagen | |
AU7232094A (en) | Bone fixation system | |
GB8500644D0 (en) | Implant in bones | |
AU3142795A (en) | Human marrow stromal cell lines which sustain hematopoiesis | |
SG49267A1 (en) | Surgical instrument and cell isolation and transplantation | |
GB8409714D0 (en) | Hip implant | |
GB9508033D0 (en) | Improvements in or relating to bone support | |
DK0746255T3 (da) | Tværgående forbindelse til spinalimplantatsystem | |
AU6039696A (en) | Myogenic differentiation of human mesenchymal stem cells | |
IL106278A0 (en) | Bone formation-inducing protein | |
GB8426866D0 (en) | Bone implants | |
GB9020035D0 (en) | Bone implant | |
GB2297264A (en) | Bone implants | |
EP0684828A4 (fr) | Expansion de cellules souches dans les cultures sur une longue duree de m lle osseuse par neutralisation du facteur de croissance transformant beta. | |
EP0747054A3 (fr) | Méthodes pour diminuer la perte osseuse | |
ZA921099B (en) | Method of lyophilization of mammalian sperm cells | |
IL129094A0 (en) | Hematopoietic stem cells and methods for generating such cells | |
GB9605308D0 (en) | Sertoli cells as transplantation facilitator for cell transplatation | |
GB9605453D0 (en) | Cultured cells | |
GB9125052D0 (en) | Culture of bone cells | |
GB8903565D0 (en) | Bone cements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950825 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE ES FR GB IT |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19960619 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): DE ES FR GB IT |
|
17Q | First examination report despatched |
Effective date: 19980901 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990312 |